These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Phenotypic and molecular characterization of pyrazinamide resistance among multidrug-resistant Mycobacterium tuberculosis isolates in Ningbo, China. Che Y; Bo D; Lin X; Chen T; He T; Lin Y BMC Infect Dis; 2021 Jun; 21(1):605. PubMed ID: 34171989 [TBL] [Abstract][Full Text] [Related]
6. Pyrazinamide resistance-conferring mutations in pncA and the transmission of multidrug resistant TB in Georgia. Sengstake S; Bergval IL; Schuitema AR; de Beer JL; Phelan J; de Zwaan R; Clark TG; van Soolingen D; Anthony RM BMC Infect Dis; 2017 Jul; 17(1):491. PubMed ID: 28697808 [TBL] [Abstract][Full Text] [Related]
8. Direct Detection of Pyrazinamide Resistance in Mycobacterium tuberculosis by Use of Tam KK; Leung KS; Siu GK; Chang KC; Wong SS; Ho PL; Leung EK; Yam WC J Clin Microbiol; 2019 Aug; 57(8):. PubMed ID: 31189582 [TBL] [Abstract][Full Text] [Related]
9. Genotypic characterization of pyrazinamide resistance in Mycobacterium tuberculosis isolated from Lusaka, Zambia. Bwalya P; Yamaguchi T; Mulundu G; Nakajima C; Mbulo G; Solo ES; Fukushima Y; Kasakwa K; Suzuki Y Tuberculosis (Edinb); 2018 Mar; 109():117-122. PubMed ID: 29559115 [TBL] [Abstract][Full Text] [Related]
10. Prevalence and molecular characterization of pyrazinamide resistance among multidrug-resistant Mycobacterium tuberculosis isolates from Southern China. Pang Y; Zhu D; Zheng H; Shen J; Hu Y; Liu J; Zhao Y BMC Infect Dis; 2017 Nov; 17(1):711. PubMed ID: 29110640 [TBL] [Abstract][Full Text] [Related]
11. Multicenter Study of the Emergence and Genetic Characteristics of Pyrazinamide-Resistant Tuberculosis in China. Li D; Hu Y; Werngren J; Mansjö M; Zheng X; Drobniewski F; Hoffner S; Xu B Antimicrob Agents Chemother; 2016 Sep; 60(9):5159-66. PubMed ID: 27297481 [TBL] [Abstract][Full Text] [Related]
12. [Investigation of pncA, rpsA and panD Gene Mutations Associated with Resistance in Pyrazinamide-Resistant Mycobacterium tuberculosis Isolates and Spoligotyping]. Özgür D; Tezcan Ülger S; Kayar MB; Biçmen C; Aslantürk A; Ülger M; Aslan G Mikrobiyol Bul; 2022 Apr; 56(2):191-205. PubMed ID: 35477224 [TBL] [Abstract][Full Text] [Related]
13. Pyrazinamide resistance among multidrug-resistant tuberculosis clinical isolates in a national referral center of China and its correlations with pncA, rpsA, and panD gene mutations. Gu Y; Yu X; Jiang G; Wang X; Ma Y; Li Y; Huang H Diagn Microbiol Infect Dis; 2016 Mar; 84(3):207-11. PubMed ID: 26775806 [TBL] [Abstract][Full Text] [Related]
14. Surveillance of pyrazinamide susceptibility among multidrug-resistant Mycobacterium tuberculosis isolates from Siriraj Hospital, Thailand. Jonmalung J; Prammananan T; Leechawengwongs M; Chaiprasert A BMC Microbiol; 2010 Aug; 10():223. PubMed ID: 20727143 [TBL] [Abstract][Full Text] [Related]
15. [Prevalence and transmission of pyrazinamide-resistant Liu BB; Hu PL; Chen ZH; Yi SL; Zhang XP; Tan YH Zhonghua Jie He He Hu Xi Za Zhi; 2022 Jul; 45(7):677-685. PubMed ID: 35768376 [No Abstract] [Full Text] [Related]
16. Characterization of pyrazinamide resistance in consecutive multidrug-resistant Mansjo M; Werngren J; Hoffner S Int J Mycobacteriol; 2017; 6(2):156-161. PubMed ID: 28559517 [TBL] [Abstract][Full Text] [Related]
17. pncA gene mutations in reporting pyrazinamide resistance among the MDR-TB suspects. Wu X; Lu W; Shao Y; Song H; Li G; Li Y; Zhu L; Chen C Infect Genet Evol; 2019 Aug; 72():147-150. PubMed ID: 30447296 [TBL] [Abstract][Full Text] [Related]
18. Underestimated pyrazinamide resistance may compromise outcomes of pyrazinamide containing regimens for treatment of drug susceptible and multi-drug-resistant tuberculosis in Tanzania. Juma SP; Maro A; Pholwat S; Mpagama SG; Gratz J; Liyoyo A; Houpt ER; Kibiki GS; Mmbaga BT; Heysell SK BMC Infect Dis; 2019 Feb; 19(1):129. PubMed ID: 30732572 [TBL] [Abstract][Full Text] [Related]
19. pncA mutations are associated with slower sputum conversion during standard treatment of multidrug-resistant tuberculosis. Zheng X; Ning Z; Drobniewski F; Yang J; Li Q; Zhang Z; Hu Y Int J Antimicrob Agents; 2017 Feb; 49(2):183-188. PubMed ID: 28012685 [TBL] [Abstract][Full Text] [Related]
20. Atypical Genetic Basis of Pyrazinamide Resistance in Monoresistant Mycobacterium tuberculosis. Modlin SJ; Marbach T; Werngren J; Mansjö M; Hoffner SE; Valafar F Antimicrob Agents Chemother; 2021 May; 65(6):. PubMed ID: 33722890 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]